BioScience Health Innovations (BHIC) Non-Current Debt (2020 - 2021)

BioScience Health Innovations (BHIC) reported Non-Current Debt of $8713.0 for Q4 2021, up 23.57% year-over-year from $7051.0 in Q4 2020, and little changed quarter-over-quarter from $8713.0 in Q3 2021.

BioScience Health Innovations (BHIC) Non-Current Debt (2020 - 2021) Analysis & Trends

BioScience Health Innovations (BHIC) has 2 years of Non-Current Debt data on file, last reported at $8713.0 in Q4 2021.

  • Non-Current Debt for Q4 2021 came in at $8713.0, up 23.57% year-over-year; the trailing twelve-month figure through Nov 2021 was $8713.0 (up 23.57% YoY), and the FY2021 annual result was $8713.0, up 1046.45% from the prior year.
  • Non-Current Debt was little changed at $8713.0 in Q4 2021 per BHIC's latest filing, from $8713.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $8713.0 in Q3 2021 and troughed at $760.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 High Tide 558.20 Mn 531.28 Mn 32.00 Mn 8.59 Mn
2 Wellgistics Health 385.01 Mn 384.95 Mn 170,221.00 12.60 Mn
3 Petmed Express 35.71 Mn 8.80 Mn 9.46 Mn -
4 Scienture Holdings 14.72 Mn 14.72 Mn 53,850.00 -
5 Ridgetech 15.50 -4.11 Mn - -
6 Scientist Home Future Health - - 32,589.00 -
7 BioScience Health Innovations - - 485,596.00 -
8 Rest Ez - - - -
9 Polomar Health Services - - 550,489.00 -

Historic Data

Download Data
DateValue
Nov 30, 2021 8,713.00
Nov 30, 2021 8,713.00
Aug 31, 2021 8,713.00
Aug 31, 2021 8,713.00
May 31, 2021 8,251.00
May 31, 2021 8,251.00
Feb 28, 2021 7,051.00
Feb 28, 2021 7,051.00
Nov 30, 2020 7,051.00
Nov 30, 2020 7,051.00
Aug 31, 2020 760.00
Aug 31, 2020 760.00